S&P 500   4,287.91 (-0.27%)
DOW   33,505.67 (-0.48%)
QQQ   357.62 (-0.11%)
AAPL   170.85 (+0.09%)
MSFT   315.64 (+0.64%)
META   301.83 (-0.70%)
GOOGL   131.15 (-0.88%)
AMZN   126.50 (+0.41%)
TSLA   248.06 (+0.68%)
NVDA   434.22 (+0.77%)
NIO   8.95 (+0.45%)
BABA   86.70 (+1.36%)
AMD   103.11 (+0.34%)
T   14.94 (-0.47%)
F   12.41 (-1.19%)
MU   67.38 (+3.34%)
CGC   0.78 (-3.69%)
GE   110.25 (-1.86%)
DIS   80.59 (+0.57%)
AMC   8.00 (+2.70%)
PFE   32.99 (+2.80%)
PYPL   58.09 (-0.15%)
NFLX   375.85 (-0.14%)
S&P 500   4,287.91 (-0.27%)
DOW   33,505.67 (-0.48%)
QQQ   357.62 (-0.11%)
AAPL   170.85 (+0.09%)
MSFT   315.64 (+0.64%)
META   301.83 (-0.70%)
GOOGL   131.15 (-0.88%)
AMZN   126.50 (+0.41%)
TSLA   248.06 (+0.68%)
NVDA   434.22 (+0.77%)
NIO   8.95 (+0.45%)
BABA   86.70 (+1.36%)
AMD   103.11 (+0.34%)
T   14.94 (-0.47%)
F   12.41 (-1.19%)
MU   67.38 (+3.34%)
CGC   0.78 (-3.69%)
GE   110.25 (-1.86%)
DIS   80.59 (+0.57%)
AMC   8.00 (+2.70%)
PFE   32.99 (+2.80%)
PYPL   58.09 (-0.15%)
NFLX   375.85 (-0.14%)
S&P 500   4,287.91 (-0.27%)
DOW   33,505.67 (-0.48%)
QQQ   357.62 (-0.11%)
AAPL   170.85 (+0.09%)
MSFT   315.64 (+0.64%)
META   301.83 (-0.70%)
GOOGL   131.15 (-0.88%)
AMZN   126.50 (+0.41%)
TSLA   248.06 (+0.68%)
NVDA   434.22 (+0.77%)
NIO   8.95 (+0.45%)
BABA   86.70 (+1.36%)
AMD   103.11 (+0.34%)
T   14.94 (-0.47%)
F   12.41 (-1.19%)
MU   67.38 (+3.34%)
CGC   0.78 (-3.69%)
GE   110.25 (-1.86%)
DIS   80.59 (+0.57%)
AMC   8.00 (+2.70%)
PFE   32.99 (+2.80%)
PYPL   58.09 (-0.15%)
NFLX   375.85 (-0.14%)
S&P 500   4,287.91 (-0.27%)
DOW   33,505.67 (-0.48%)
QQQ   357.62 (-0.11%)
AAPL   170.85 (+0.09%)
MSFT   315.64 (+0.64%)
META   301.83 (-0.70%)
GOOGL   131.15 (-0.88%)
AMZN   126.50 (+0.41%)
TSLA   248.06 (+0.68%)
NVDA   434.22 (+0.77%)
NIO   8.95 (+0.45%)
BABA   86.70 (+1.36%)
AMD   103.11 (+0.34%)
T   14.94 (-0.47%)
F   12.41 (-1.19%)
MU   67.38 (+3.34%)
CGC   0.78 (-3.69%)
GE   110.25 (-1.86%)
DIS   80.59 (+0.57%)
AMC   8.00 (+2.70%)
PFE   32.99 (+2.80%)
PYPL   58.09 (-0.15%)
NFLX   375.85 (-0.14%)
NASDAQ:HZNP

Horizon Therapeutics Public (HZNP) Earnings Date, Estimates & Call Transcripts

$115.69
0.00 (0.00%)
(As of 01:14 PM ET)
Compare
Today's Range
$115.66
▼
$115.75
50-Day Range
$98.98
▼
$115.74
52-Week Range
$60.03
▼
$115.87
Volume
984,452 shs
Average Volume
2.33 million shs
Market Capitalization
$26.49 billion
P/E Ratio
61.87
Dividend Yield
N/A
Price Target
$110.71
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Nov. 1Estimated
Actual EPS
(Aug. 8)
$1.20 Beat By $0.08
Consensus EPS
(Aug. 8)
$1.12
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

HZNP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

HZNP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Horizon Therapeutics Public Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20233$1.12$1.56$1.28 
Q2 20234$1.13$1.85$1.34 
Q3 20233$1.17$2.00$1.58 
Q4 20234$1.23$2.15$1.71 
FY 202314$4.65$7.56 $5.90

HZNP Earnings Date and Information

Horizon Therapeutics Public last posted its earnings results on August 8th, 2023. The biopharmaceutical company reported $1.20 earnings per share for the quarter, topping analysts' consensus estimates of $1.12 by $0.08. The company had revenue of $945 million for the quarter, compared to analysts' expectations of $873.52 million. Its quarterly revenue was up 7.8% compared to the same quarter last year. Horizon Therapeutics Public has generated $1.87 earnings per share over the last year ($1.87 diluted earnings per share) and currently has a price-to-earnings ratio of 61.9. Earnings for Horizon Therapeutics Public are expected to grow by 42.19% in the coming year, from $4.29 to $6.10 per share. Horizon Therapeutics Public has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 1st, 2023 based off prior year's report dates.

Horizon Therapeutics Public Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/1/2023
Estimated)		------- 
8/8/2023Q2 2023$1.12$1.20+$0.08$1.86$873.52 million$945.00 million
5/3/2023Q1 2023$1.17$0.83($0.34)$1.43$897.06 million$832.10 million    
3/1/2023Q4 2022$1.09$1.21+$0.12$1.90$922.95 million$942.03 million
11/2/2022Q3 2022$1.00$1.25+$0.25$1.92$888.93 million$925.36 million
8/3/2022Q2 2022$1.35$1.07($0.28)$1.88$938.82 million$876.40 million    
5/4/2022Q1 2022$1.15$1.34+$0.19$1.81$866.39 million$885.25 million    
3/1/2022Q4 2021$1.27$1.41+$0.14$2.09$995.90 million$1.01 billion    
11/3/2021Q3 2021$1.54$1.75+$0.21$2.12$979.49 million$1.04 billion    
8/3/2021Q2 2021$0.87$1.62+$0.75$2.57$697.69 million$832.55 million    
5/5/2021Q1 2021$0.07$0.03($0.04)$0.61$389.51 million$342.41 million  
2/23/2021Q4 2020$1.06$1.28+$0.22$1.74$694.20 million$745.31 million  
11/7/2020Q3 2020$0.97$1.74+$0.77$2.17$531.11 million$636.40 million  












Horizon Therapeutics Public Earnings - Frequently Asked Questions

When is Horizon Therapeutics Public's earnings date?

Horizon Therapeutics Public has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 1st, 2023 based off last year's report dates. Learn more on HZNP's earnings history.

Did Horizon Therapeutics Public beat their earnings estimates last quarter?

In the previous quarter, Horizon Therapeutics Public (NASDAQ:HZNP) reported $1.20 earnings per share (EPS) to beat the analysts' consensus estimate of $1.12 by $0.08. Learn more on analysts' earnings estimate vs. HZNP's actual earnings.

How much revenue does Horizon Therapeutics Public generate each year?

Horizon Therapeutics Public (NASDAQ:HZNP) has a recorded annual revenue of $3.63 billion.

How much profit does Horizon Therapeutics Public generate each year?

Horizon Therapeutics Public (NASDAQ:HZNP) has a recorded net income of $521.48 million. HZNP has generated $1.87 earnings per share over the last four quarters.

What is Horizon Therapeutics Public's price-to-earnings ratio?

Horizon Therapeutics Public (NASDAQ:HZNP) has a trailing price-to-earnings ratio of 61.88 and a forward price-to-earnings ratio of 26.97. The price/earnings-to-growth ratio is 3.85.

What is Horizon Therapeutics Public's EPS forecast for next year?

Horizon Therapeutics Public's earnings are expected to grow from $4.29 per share to $6.10 per share in the next year, which is a 42.19% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:HZNP) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -